The European Food Safety Authority (EFSA; Parma, Italy) has approved a health claim for a sugar-free chewing gum intended to reduce tooth decay. The Article 14 health claim was submitted by Wrigley GmbH (Munich) for a chewing gum that contains xylitol, sorbitol, and mannitol.
The European Food Safety Authority (EFSA; Parma, Italy) has approved a health claim for a sugar-free chewing gum intended to reduce tooth decay. The Article 14 health claim was submitted by Wrigley GmbH (Munich) for a chewing gum that contains xylitol, sorbitol, and mannitol.
Wrigley’s claimed effect is that the “sugar-free chewing gum maintains tooth mineralization which reduces the risk of dental caries.”
Providing EFSA with 21 human intervention studies, and 37 publications overall, the agency’s panel on dietetic products, nutrition, and allergies (NDA Panel) concluded that “strong evidence supporting the biological plausibility for the effect” was provided.
“The de- and remineralization equilibrium of teeth is mainly driven by saliva and the main contributors are flow rate and concentrations of calcium, phosphate, and bicarbonate,” wrote the NDA Panel in its opinion. “At rest, low amounts of saliva are secreted, but stimulation by chewing may increase saliva flow more than ten-fold. When flow rate increases, saliva concentration of calcium, phosphate and bicarbonate also increases, and such increases favor remineralization of tooth crystals.”
In order to receive the desired effect of the chewing gum, EFSA has suggested that 2-3 g of the gum be chewed for 20 minutes at least three times per day after meals.
FDA revokes authorization to use Red No. 3 as a color additive in food or drugs
January 15th 2025FDA contends that the color additive is safe for humans but is legally obligated by the Delaney Clause of the FD&C act to revoke authorization as research shows the Red No. 3 induces cancer in rats.
Magnesium L-threonate, Magtein, earns novel food authorization in the European Union
December 19th 2024According to the announcement, the authorization is also exclusive to AIDP and its partner company and licensee, ThreoTech, meaning that they are the only parties that can market magnesium L-threonate in the EU for a period of five years.